Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 464-700-1 | CAS number: 607724-42-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The test substance is considered to be of low acute oral and dermal toxicity with LD50 values >2,000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From Mar. 22, 2005 to Apr. 06, 2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann GmbH, Gartenstrasse 27. D-33178 Borchen
- Age at study initiation: 6-10 weeks
- Weight at study initiation: 178.5± 8.8 g (mean)
- Fasting period before study: yes
- Housing: In transparent macrolon® cages (type IV) on soft wood granulate in an air-conditioned room, 3 animals per cage
- Diet: ssniff® R/M-H (V 1534), ad libitum
- Water: tap water in plastic bottles, ad libitum
- Acclimation period: At least 5 d
- Animal identification: fur marking with KMnO4 and cage numbering
ENVIRONMENTAL CONDITIONS
- Temperature: 22±3°C (short lasting deviations were permissible, e.g., during cleaning processes)
- Humidity: 50±20%
- Photoperiod: 12 h light/dark cycle
IN-LIFE DATES: From Mar. 22, 2005 to Apr. 06, 2005 - Route of administration:
- oral: gavage
- Vehicle:
- other: deionized water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 20% suspension in deionized water
- Amount of vehicle (if gavage): 10 mL/kg bw
DOSAGE PREPARATION: Test substance was suspended in the stated concentration in deionized water and distributed homogeneously by means of a magnetic stirrer
CLASS METHOD: Acute toxic class method
- Rationale for the selection of the starting dose: The acute oral toxicity of test substance was tested only at a dose level of 2,000 mg/kg bw (limit test) according to toxicity data of related compounds. The animals received the test substance as a 20% suspension in deionized water, the administration volume was 10 mL/kg bw. As no compound-related mortality was produced in this limit test, no further dose was tested. - Doses:
- 2,000 mg/kg bw
- No. of animals per sex per dose:
- 6
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 d
- Frequency of observations and weighing: Twice every day (in the morning and in the afternoon), on weekends and public holidays only once
- Necropsy of survivors performed: yes
- Other examinations performed: Mortality, body weight, clinical observations and macroscopic examinations - Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths occurred during the whole study.
- Clinical signs:
- other: Dark red discolored feces was the only clinical sign observed in the animals at the time point of 4-8 h after the administration of the test substance: From Day 2 until the end of the study no symptoms were observed.
- Gross pathology:
- The animals killed at the end of the observation period showed no macroscopically visible changes.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the test conditions, the oral LD50 value for the test substance was found to be >2000 mg/kg bw.
- Executive summary:
A study was conducted to assess the acute toxicity of the test substance on rats according to EU Method B.1 and OECD Guideline 423, in compliance with GLP.
The substance was tested only at a dose of 2,000 mg/kg bw (limit test). The substance was administered by gavage to fasted animals as a 20% suspension in deionized water. The administration volume was 10 mL/kg bw. The observation period following treatment lasted for 14 d. Symptoms were recorded twice every day (in the morning and in the afternoon), on weekends and public holidays only once. During this time, the animals were weighed weekly. At the end of the observation period, the animals were sacrificed by carbon dioxide asphyxiation, dissected and examined for macroscopically visible changes.
No mortality or adverse effect on development of body weight was observed. No clinical signs, except discoloured feces at the time point of 4-8 h after administration, were observed. The macroscopic examination after sacrifice did not reveal any adverse effects.
Hence, under the test conditions, the oral LD50 was > 2,000 mg/kg bw (Kauffmann, 2005a).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- High quality study.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From Mar. 30, 2005 to Apr. 13, 2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann GmbH, Gartenstrasse 27, D-33178, Borchen.
- Age at study initiation: 6-10 weeks
- Weight at study initiation: 248.8±15.4 g (males); 215.2±5.6 g (females)
- Housing: in transparent macrolon® cages (type III) on soft wood granulate* in an air-conditioned room, 1 animal per cage
- Diet: ssniff® R/M-H (V 1534), ad libitum
- Water: tap water in plastic bottles, ad libitum
- Acclimation period: At least 5 d
ENVIRONMENTAL CONDITIONS
- Temperature: 22±3°C
- Humidity: 50±20 %
- Photoperiod: 12 h light/dark cycle
IN-LIFE DATES: From Mar. 30, 2005 to Apr. 13, 2005 - Type of coverage:
- semiocclusive
- Vehicle:
- water
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 30cm2
- Type of wrap if used: Fixomull and Elastoplast
REMOVAL OF TEST SUBSTANCE
- Washing: With warm water
- Time after start of exposure: 24 h
TEST MATERIAL
- Amount(s) applied: 0.5 g
- For solids, paste formed: yes
VEHICLE
- Amount(s) applied: 0.3 mL - Duration of exposure:
- 24 h
- Doses:
- 2,000 mg/kg bw
- No. of animals per sex per dose:
- 5/sex
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 d
- Frequency of observations and weighing: Twice every day (in the morning and in the afternoon), on weekends and public holidays only once.
- Necropsy of survivors performed: yes
- Other examinations performed: Mortality, body weight, clinical observations and macroscopical examinations
- Overall study design: Before dermal treatment the fur was mechanically removed from the dorsal skin of the animals over an area of approximately 30 cm². 0.5 g test substance was moistened with 0.3 mL deionized water on a two-ply gauze and an aluminum foil (6x8 cm) and distributed as uniformly as possible. Together with the foil the test substance was administered to the shaved and intact dorsal skin. The foil was held in place with an elastic plaster bandage fixed around the animal's body (Fixomull and Elastoplast, 8 cm in width, both manufactured by Beiersdorf Aktiengesellschaft).
At the end of the dermal exposure period of 24 h the bandage was removed and the treated skin area washed with warm water in order to remove any unabsorbed remnants of the test substance.
The observation period after the dermal administration lasted for 14 d. Symptoms were recorded twice every day (in the morning and in the afternoon), on weekends and public holidays only once. During this time the animals were weighed weekly. At the end of the observation period the animals were sacrificed by carbon dioxide asphyxiation, dissected and examined for macroscopically visible changes. - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths occurred during the whole study
- Clinical signs:
- other: No test substance related symptoms were observed after administration of 2,000 mg/kg bw. The skin of the animals showed substance related discolorations (by compound) starting on Day 2 in all animals and lasting up to Day 13 of the study on some animals.
- Gross pathology:
- The animals killed at the end of the observation period showed no macroscopically visible changes.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the test conditions, the dermal LD50 value for the test substance was found to be >2000 mg/kg bw.
- Executive summary:
A study was conducted to assess the acute toxicity of the test substance on rats according to EU Method B.3 and OECD Guideline 402, in compliance with GLP.
The animals (5/sex) were exposed to the test substance at the dose rate of 2,000 mg/kg bw for the period of 24 h. At the end of the dermal exposure period, the bandage was removed and the treated skin area washed with warm water in order to remove any unabsorbed remnants of the test substance. The observation period after the dermal administration lasted for 14 d. Symptoms were recorded twice every day (in the morning and in the afternoon), on weekends and public holidays only once. During this time the animals were weighed weekly. At the end of the observation period the animals were sacrificed by carbon dioxide asphyxiation, dissected and examined for macroscopically visible changes.
No deaths occurred during the whole study. One female animal showed a slight loss of body weight at the end of the study. In the other female and male animals development of body weight was not impaired. No test substance related symptoms were observed after administration of 2,000 mg/kg bw. The skin of the animals showed substance related discolorations (by compound) starting on Day 2 in all animals and lasting up to Day 13 of the study on some animals.
Hence, under the test conditions, the dermal LD50 value for the test substance was found to be >2,000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- High quality study
Additional information
Oral route:
A study was conducted to assess the acute toxicity of the test substance on rats according to EU Method B.1 and OECD Guideline 423, in compliance with GLP. The substance was tested only at a dose of 2,000 mg/kg bw (limit test). The substance was administered by gavage to fasted animals as a 20% suspension in deionized water. The administration volume was 10 mL/kg bw. The observation period following treatment lasted for 14 d. Symptoms were recorded twice every day (in the morning and in the afternoon), on weekends and public holidays only once. During this time, the animals were weighed weekly. At the end of the observation period, the animals were sacrificed by carbon dioxide asphyxiation, dissected and examined for macroscopically visible changes. No mortality or adverse effect on development of body weight was observed. No clinical signs, except discoloured feces at the time point of 4-8 h after administration, were observed. The macroscopic examination after sacrifice did not reveal any adverse effects. Hence, under the test conditions, the oral LD50 was > 2,000 mg/kg bw (Kauffmann, 2005b).
Dermal route:
A study was conducted to assess the acute toxicity of the test substance on rats according to EU Method B.3 and OECD Guideline 402, in compliance with GLP. The animals (5/sex) were exposed to the test substance at the dose rate of 2,000 mg/kg bw for the period of 24 h. At the end of the dermal exposure period, the bandage was removed and the treated skin area washed with warm water in order to remove any unabsorbed remnants of the test substance. The observation period after the dermal administration lasted for 14 d. Symptoms were recorded twice every day (in the morning and in the afternoon), on weekends and public holidays only once. During this time the animals were weighed weekly. At the end of the observation period the animals were sacrificed by carbon dioxide asphyxiation, dissected and examined for macroscopically visible changes. No deaths occurred during the whole study. One female animal showed a slight loss of body weight at the end of the study. In the other female and male animals development of body weight was not impaired. No test substance related symptoms were observed after administration of 2,000 mg/kg bw. The skin of the animals showed substance related discolorations (by compound) starting on Day 2 in all animals and lasting up to Day 13 of the study on some animals. Hence, under the test conditions, the dermal LD50 value for the test substance was found to be >2,000 mg/kg bw (Kauffmann, 2005c).
Justification for classification or non-classification
Oral route:
Based on the results of an acute oral toxicity study, the test substance does not need to be classified for this endpoint according to the EU CLP criteria (EC 1272/2008) as well as EU Directive 67/548/EEC.
Dermal route:
Based on the results of an acute dermal toxicity study, the test substance does not need to be classified for this endpoint according to the EU CLP criteria (EC 1272/2008) as well as EU Directive 67/548/EEC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.